Asset
FUNAPIDE
Xenon Pharmaceuticals Inc. Common Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01195636 | phase2 | completed | 2010-08-01 | 2011-03-01 | Xenon Pharmaceuticals Inc. | A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN) |
| NCT01486446 | phase1_2 | completed | 2011-12-01 | 2012-04-01 | Xenon Pharmaceuticals Inc. | Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia |
FDA applications (0)
This company has no applications containing this asset.